Literature DB >> 25700176

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.

Elizabeth T Cirulli1, Brittany N Lasseigne2, Slavé Petrovski3, Peter C Sapp4, Patrick A Dion5, Claire S Leblond5, Julien Couthouis6, Yi-Fan Lu3, Quanli Wang3, Brian J Krueger3, Zhong Ren3, Jonathan Keebler7, Yujun Han7, Shawn E Levy2, Braden E Boone2, Jack R Wimbish2, Lindsay L Waite2, Angela L Jones2, John P Carulli8, Aaron G Day-Williams8, John F Staropoli8, Winnie W Xin9, Alessandra Chesi6, Alya R Raphael6, Diane McKenna-Yasek4, Janet Cady10, J M B Vianney de Jong11, Kevin P Kenna12, Bradley N Smith13, Simon Topp13, Jack Miller13, Athina Gkazi13, Ammar Al-Chalabi13, Leonard H van den Berg14, Jan Veldink14, Vincenzo Silani15, Nicola Ticozzi15, Christopher E Shaw13, Robert H Baloh16, Stanley Appel17, Ericka Simpson17, Clotilde Lagier-Tourenne18, Stefan M Pulst19, Summer Gibson19, John Q Trojanowski20, Lauren Elman21, Leo McCluskey21, Murray Grossman22, Neil A Shneider23, Wendy K Chung24, John M Ravits25, Jonathan D Glass26, Katherine B Sims9, Vivianna M Van Deerlin20, Tom Maniatis27, Sebastian D Hayes28, Alban Ordureau29, Sharan Swarup29, John Landers4, Frank Baas11, Andrew S Allen30, Richard S Bedlack31, J Wade Harper29, Aaron D Gitler6, Guy A Rouleau5, Robert Brown4, Matthew B Harms10, Gregory M Cooper2, Tim Harris32, Richard M Myers2, David B Goldstein3.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a devastating neurological disease with no effective treatment. We report the results of a moderate-scale sequencing study aimed at increasing the number of genes known to contribute to predisposition for ALS. We performed whole-exome sequencing of 2869 ALS patients and 6405 controls. Several known ALS genes were found to be associated, and TBK1 (the gene encoding TANK-binding kinase 1) was identified as an ALS gene. TBK1 is known to bind to and phosphorylate a number of proteins involved in innate immunity and autophagy, including optineurin (OPTN) and p62 (SQSTM1/sequestosome), both of which have also been implicated in ALS. These observations reveal a key role of the autophagic pathway in ALS and suggest specific targets for therapeutic intervention.
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25700176      PMCID: PMC4437632          DOI: 10.1126/science.aaa3650

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  61 in total

1.  Triggering the interferon antiviral response through an IKK-related pathway.

Authors:  Sonia Sharma; Benjamin R tenOever; Nathalie Grandvaux; Guo-Ping Zhou; Rongtuan Lin; John Hiscott
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  Antisense oligonucleotide therapy for neurodegenerative disease.

Authors:  Richard A Smith; Timothy M Miller; Koji Yamanaka; Brett P Monia; Thomas P Condon; Gene Hung; Christian S Lobsiger; Chris M Ward; Melissa McAlonis-Downes; Hongbing Wei; Ed V Wancewicz; C Frank Bennett; Don W Cleveland
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

3.  Early-onset ALS with long-term survival associated with spastin gene mutation.

Authors:  T Meyer; A Schwan; J S Dullinger; J Brocke; K-T Hoffmann; C H Nolte; A Hopt; U Kopp; P Andersen; J T Epplen; P Linke
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

4.  The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis.

Authors:  Y Yang; A Hentati; H X Deng; O Dabbagh; T Sasaki; M Hirano; W Y Hung; K Ouahchi; J Yan; A C Azim; N Cole; G Gascon; A Yagmour; M Ben-Hamida; M Pericak-Vance; F Hentati; T Siddique
Journal:  Nat Genet       Date:  2001-10       Impact factor: 38.330

5.  D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.

Authors:  Jumpei Sasabe; Tomohiro Chiba; Marina Yamada; Koichi Okamoto; Ikuo Nishimoto; Masaaki Matsuoka; Sadakazu Aiso
Journal:  EMBO J       Date:  2007-08-30       Impact factor: 11.598

6.  Human Gene Mutation Database (HGMD): 2003 update.

Authors:  Peter D Stenson; Edward V Ball; Matthew Mort; Andrew D Phillips; Jacqueline A Shiel; Nick S T Thomas; Shaun Abeysinghe; Michael Krawczak; David N Cooper
Journal:  Hum Mutat       Date:  2003-06       Impact factor: 4.878

7.  Enhanced binding of TBK1 by an optineurin mutant that causes a familial form of primary open angle glaucoma.

Authors:  Simon Morton; Luke Hesson; Mark Peggie; Philip Cohen
Journal:  FEBS Lett       Date:  2008-02-26       Impact factor: 4.124

8.  Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.

Authors:  M G Wathelet; C H Lin; B S Parekh; L V Ronco; P M Howley; T Maniatis
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970

9.  Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.

Authors:  Siqi Liu; Xin Cai; Jiaxi Wu; Qian Cong; Xiang Chen; Tuo Li; Fenghe Du; Junyao Ren; You-Tong Wu; Nick V Grishin; Zhijian J Chen
Journal:  Science       Date:  2015-01-29       Impact factor: 47.728

10.  The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection.

Authors:  Hiroaki Hemmi; Osamu Takeuchi; Shintaro Sato; Masahiro Yamamoto; Tsuneyasu Kaisho; Hideki Sanjo; Taro Kawai; Katsuaki Hoshino; Kiyoshi Takeda; Shizuo Akira
Journal:  J Exp Med       Date:  2004-06-21       Impact factor: 14.307

View more
  388 in total

Review 1.  Genes, pathways, and animal models in primary open-angle glaucoma.

Authors:  A I Iglesias; H Springelkamp; W D Ramdas; C C W Klaver; R Willemsen; C M van Duijn
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

Review 2.  Familial Amyotrophic Lateral Sclerosis.

Authors:  Kevin Boylan
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 3.  [Amyotrophic lateral sclerosis. Multisystem degeneration].

Authors:  A Hübers; A C Ludolph; A Rosenbohm; E H Pinkhardt; J H Weishaupt; J Dorst
Journal:  Nervenarzt       Date:  2016-02       Impact factor: 1.214

4.  TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.

Authors:  Jonathan P Ling; Olga Pletnikova; Juan C Troncoso; Philip C Wong
Journal:  Science       Date:  2015-08-07       Impact factor: 47.728

Review 5.  Genetics of Bipolar Disorder: Recent Update and Future Directions.

Authors:  Fernando S Goes
Journal:  Psychiatr Clin North Am       Date:  2016-03

Review 6.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

7.  Structural Correlates of CA2 and CA3 Pyramidal Cell Activity in Freely-Moving Mice.

Authors:  Lingjun Ding; Hongbiao Chen; Maria Diamantaki; Stefano Coletta; Patricia Preston-Ferrer; Andrea Burgalossi
Journal:  J Neurosci       Date:  2020-06-18       Impact factor: 6.167

8.  Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation.

Authors:  Faxiang Li; Daichao Xu; Yingli Wang; Zixuan Zhou; Jianping Liu; Shichen Hu; Yukang Gong; Junying Yuan; Lifeng Pan
Journal:  Autophagy       Date:  2018-02-02       Impact factor: 16.016

9.  Association of Rare CYP39A1 Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye.

Authors:  Zheng Li; Zhenxun Wang; Mei Chin Lee; Matthias Zenkel; Esther Peh; Mineo Ozaki; Fotis Topouzis; Satoko Nakano; Anita Chan; Shuwen Chen; Susan E I Williams; Andrew Orr; Masakazu Nakano; Nino Kobakhidze; Tomasz Zarnowski; Alina Popa-Cherecheanu; Takanori Mizoguchi; Shin-Ichi Manabe; Ken Hayashi; Shigeyasu Kazama; Kenji Inoue; Yosai Mori; Kazunori Miyata; Kazuhisa Sugiyama; Tomomi Higashide; Etsuo Chihara; Ryuichi Ideta; Satoshi Ishiko; Akitoshi Yoshida; Kana Tokumo; Yoshiaki Kiuchi; Tsutomu Ohashi; Toshiya Sakurai; Takako Sugimoto; Hideki Chuman; Makoto Aihara; Masaru Inatani; Kazuhiko Mori; Yoko Ikeda; Morio Ueno; Daniel Gaston; Paul Rafuse; Lesya Shuba; Joseph Saunders; Marcelo Nicolela; George Chichua; Sergo Tabagari; Panayiota Founti; Kar Seng Sim; Wee Yang Meah; Hui Meng Soo; Xiao Yin Chen; Anthi Chatzikyriakidou; Christina Keskini; Theofanis Pappas; Eleftherios Anastasopoulos; Alexandros Lambropoulos; Evangelia S Panagiotou; Dimitrios G Mikropoulos; Ewa Kosior-Jarecka; Augustine Cheong; Yuanhan Li; Urszula Lukasik; Monisha E Nongpiur; Rahat Husain; Shamira A Perera; Lydia Álvarez; Montserrat García; Héctor González-Iglesias; Andrés Fernández-Vega Cueto; Luis Fernández-Vega Cueto; Federico Martinón-Torres; Antonio Salas; Çilingir Oguz; Nevbahar Tamcelik; Eray Atalay; Bilge Batu; Murat Irkec; Dilek Aktas; Burcu Kasim; Yury S Astakhov; Sergei Y Astakhov; Eugeny L Akopov; Andreas Giessl; Christian Mardin; Claus Hellerbrand; Jessica N Cooke Bailey; Robert P Igo; Jonathan L Haines; Deepak P Edward; Steffen Heegaard; Sonia Davila; Patrick Tan; Jae H Kang; Louis R Pasquale; Friedrich E Kruse; André Reis; Trevor R Carmichael; Michael Hauser; Michele Ramsay; Georg Mossböck; Nilgun Yildirim; Kei Tashiro; Anastasios G P Konstas; Miguel Coca-Prados; Jia Nee Foo; Shigeru Kinoshita; Chie Sotozono; Toshiaki Kubota; Michael Dubina; Robert Ritch; Janey L Wiggs; Francesca Pasutto; Ursula Schlötzer-Schrehardt; Ying Swan Ho; Tin Aung; Wai Leong Tam; Chiea Chuen Khor
Journal:  JAMA       Date:  2021-02-23       Impact factor: 56.272

10.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging.

Authors:  Daichao Xu; Taijie Jin; Hong Zhu; Hongbo Chen; Dimitry Ofengeim; Chengyu Zou; Lauren Mifflin; Lifeng Pan; Palak Amin; Wanjin Li; Bing Shan; Masanori Gomi Naito; Huyan Meng; Ying Li; Heling Pan; Liviu Aron; Xian Adiconis; Joshua Z Levin; Bruce A Yankner; Junying Yuan
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.